What Boehringer Ingelheim Pharmaceuticals, Inc. pays H-1B Scientists

Boehringer Ingelheim Pharmaceuticals, Inc. filed 10 certified H-1B LCAs for Scientist roles in FY2025-FY2026. In FY2026 (October to June), the middle half of its 5 filings stated $140,500 to $145,000 a year, with a median of $142,000.

Median, FY2026 so far$142,000
Middle half$140,500 to $145,000
Certified LCAs, FY2025-FY202610

By fiscal year

YearLCAsMedianMiddle halfLowest to highestPrevailing wage
FY2026 so far5$142,000$140,500 to $145,000$86,520 to $172,095$120,224
FY20255$142,000$106,850 to $145,000$84,000 to $183,475$106,850

Prevailing wage is the median of the DOL prevailing wage on the same filings: the floor the law sets for that job and place.

By prevailing-wage level

LevelLCAsMedianMiddle half
Level I (entry)1$84,000too few
Level II (qualified)4$143,500$133,213 to $145,000
Level III (experienced)2$129,308too few
Level IV (fully competent)3$142,000too few

Level I is entry and Level IV is fully competent, as the employer classified the position. Seniority words in the job title are folded into one title here; the level is where seniority shows.

By worksite

WorksiteLCAsMedianLowest to highest
Ridgefield, CT8$143,500$86,520 to $183,475

Titles grouped here

Filed as Medical Scientists, Except Epidemiologists (SOC 19-1042).

Applying to Boehringer Ingelheim Pharmaceuticals, Inc.?

Nyanza puts these filings next to any Scientist posting you check, so you know what the employer has stated before the first call.

Other titles at Boehringer Ingelheim Pharmaceuticals, Inc.